1-9 of 9
Langdon L Miller, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

VLS-101, a ROR1-Targeting Antibody-Drug Conjugate, Demonstrates a Predictable Safety Profile and Clinical Efficacy in Patients with Heavily Pretreated Mantle Cell Lymphoma and Diffuse Large B-Cell Lymphoma

Michael Wang, MD, Jacqueline C. Barrientos, MD, Richard R. Furman, MD, Matthew Mei, MD, Paul M. Barr, MD, Michael Y. Choi, MD, Sven de Vos, MD PhD, Avyakta Kallam, MD, Krish Patel, MD, Simon Rule, MD PhD, Kate Flanders, BS, Katti A. Jessen, PhD, Peter C. Riebling, Patricia Graham, BHSA, Lydia King, PhD, Elizabeth M. Schmidt, BSN, Brian J. Lannutti, PhD, David M. Johnson, BS, Langdon L. Miller, MD, Stephen E. Spurgeon, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 13–14.
https://doi.org/10.1182/blood-2020-136373
Published: 2020
Journal Articles

LAM-003, a Novel Oral Heat Shock Protein 90 Inhibitor for Treatment of Acute Myeloid Leukemia, Including Wild-Type and FMS-like Tyrosine Kinase 3 (FLT3)-Mutant Disease

Neil Beeharry, Sean Landrette, PhD, Jeff Grotzke, PhD, Sophia Gayle, PhD, Marylens Hernandez, PhD, Stephanie Halene, MD, Peter R Young, PhD, Langdon L Miller, MD, Tian Xu, PhD, Jonathan Rothberg, PhD, Henri Lichenstein, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2664.
https://doi.org/10.1182/blood-2019-125770
Published: 2019
Journal Articles

A Phase 1-2 Dose-Escalation and Cohort- Expansion Study of eFT508, a Selective, Orally Bioavailable Inhibitor of MNK1 and MNK2, in Patients with Hematological Malignancies

Ajay K. Gopal, MD, Rod Ramchandren, MD, Nashat Y. Gabrail, Manish R Patel, MD, Ding Wang, MDPhD, Langdon L Miller, MD, Vikas Goel, PhD, Gary G Chiang, PhD, Kevin R Webster, PhD, Sam Sperry, PhD, Debra T Vallner, PhDMBA, Cara Casseday, BSc MBA, Jeremy Barton, MBBS
Journal: Blood
Blood (2017) 130 (Supplement 1): 4624.
https://doi.org/10.1182/blood.V130.Suppl_1.4624.4624
Published: 2017
Journal Articles

Phase 1 Clinical Safety, Pharmacokinetics (PK), and Activity of Apilimod Dimesylate (LAM-002A), a First-in-Class Inhibitor of Phosphatidylinositol-3-Phosphate 5-Kinase (PIKfyve), in Patients with Relapsed or Refractory B-Cell Malignancies

Wael A Harb, MD, Catherine S Diefenbach, MD, Nehal Lakhani, MD PhD, Sarah C Rutherford, MD, Marshall T Schreeder, MD, Stephen M Ansell, MD PhD, Taimur Sher, MD, David M Aboulafia, MD, Jonathon B Cohen, MDMS, Darrell Nix, BS, PhD, Sean Landrette, PhD, Kate Flanders, BS, Langdon L Miller, MD, Henri Lichenstein, PhD, Jeremy S. Abramson, MD MMSc
Journal: Blood
Blood (2017) 130 (Supplement 1): 4119.
https://doi.org/10.1182/blood.V130.Suppl_1.4119.4119
Published: 2017
Journal Articles

First-in-Human Phase 1a Study of the Safety, Pharmacokinetics, and Pharmacodynamics of the Noncovalent Bruton Tyrosine Kinase (BTK) Inhibitor SNS-062 in Healthy Subjects

Linda L. Neuman, MD MBA, Renee Ward, MD PhD, David Arnold, Daniel L. Combs, BS, Deena Gruver, MS, Wendy Hill, MBA, Josué Mfopou Kunjom, MD PhD, Langdon L. Miller, MD, Judith A. Fox, PhD
Journal: Blood
Blood (2016) 128 (22): 2032.
https://doi.org/10.1182/blood.V128.22.2032.2032
Published: 2016
Journal Articles

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Idelalisib and Rituximab for Previously Treated Patients with Chronic Lymphocytic Leukemia (CLL)

Richard R. Furman, MD, Jeff P. Sharman, MD, Steven E. Coutre, MD, Bruce D. Cheson, MD, John M. Pagel, MD, PhD, Peter Hillmen, MBChB, PhD, Jacqueline C. Barrientos, MD, Andrew D. Zelenetz, MD, PhD, Thomas J. Kipps, MD, PhD, Ian Flinn, MD, PhD, Paolo Ghia, MD, PhD, Herbert Eradat, MD, Thomas Ervin, MD, Nicole Lamanna, MD, Michael Hallek, MD, Bertrand Coiffier, MD, PhD, Andrew R. Pettitt, PhD, FRCPath, Shuo Ma, MD, PhD, Stephan Stilgenbauer, MD, Paula Cramer, MD, Maria Aiello, Dave M. Johnson, Langdon L. Miller, MD, Daniel Li, PhD, Thomas M. Jahn, MD, PhD, Roger D. Dansey, MD, Susan M. O'Brien, MD
Journal: Blood
Blood (2013) 122 (21): LBA-6.
https://doi.org/10.1182/blood.V122.21.LBA-6.LBA-6
Published: 2013
Journal Articles

Combinations of the Selective Phosphatidylinositol 3-Kinase-Delta (PI3Kdelta) Inhibitor GS–1101 (CAL-101) with Rituximab and/or Bendamustine Are Tolerable and Highly Active in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL): Results From a Phase I Study

Steven E. Coutre, MD, John P. Leonard, MD, Richard R. Furman, MD, Jacqueline C. Barrientos, MD, Sven de Vos, MD, PhD, Ian W. Flinn, MD, PhD, Marshall T. Schreeder, MD, Nina D. Wagner-Johnston, MD, Jeff Sharman, MD, Thomas E. Boyd, MD, Nathan H Fowler, MD, Leanne M. Holes, Brian J. Lannutti, PhD, Dave M. Johnson, Langdon L Miller, MD, Thomas M. Jahn, MD/PhD
Journal: Blood
Blood (2012) 120 (21): 191.
https://doi.org/10.1182/blood.V120.21.191.191
Published: 2012
Journal Articles

Combinations of the Phosphatidylinositol 3-Kinase-Delta (PI3Kδ) Inhibitor Gs-1101 (CAL-101) with Rituximab and/or Bendamustine Are Tolerable and Highly Active in Previously Treated, Indolent Non-Hodgkin Lymphoma: Results From a Phase I Study

Nathan H Fowler, MD, Sven de Vos, MD, PhD, Marshall T. Schreeder, MD, John P. Leonard, MD, Ian W. Flinn, MD, PhD, Steve Coutre, MD, Nina D. Wagner-Johnston, MD, Jeff Sharman, MD, Ralph V. Boccia, MD, Jacqueline C. Barrientos, MD, Thomas E. Boyd, MD, Leanne M. Holes, Brian J. Lannutti, PhD, David Johnson, Thomas M. Jahn, MD/PhD, Langdon L Miller, MD, Wayne R Godfrey, MD
Journal: Blood
Blood (2012) 120 (21): 3645.
https://doi.org/10.1182/blood.V120.21.3645.3645
Published: 2012
Journal Articles

Clinical Pharmacokinetics of CAL-101, a p110δ Isoform-Selective PI3K Inhibitor, Following Single- and Multiple-Dose Administration In Healthy Volunteers and Patients with Hematological Malignancies

Heather K Webb, Ph.D., Hao Chen, Ph.D., Albert S Yu, M.D., Sissy Peterman, Leanne Holes, Brian Lannutti, PhD, Langdon L. Miller, MD, Roger G Ulrich, Ph.D.
Journal: Blood
Blood (2010) 116 (21): 1774.
https://doi.org/10.1182/blood.V116.21.1774.1774
Published: 2010